Marcus Schindler
Chief Tech/Sci/R&D Officer at NOVO NORDISK A/S
Network origin in Marcus Schindler first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Cambridge
240
| College/University | Other Consumer Services | 240 |
| Public Company | Pharmaceuticals: Major | 47 | |
| Public Company | Pharmaceuticals: Major | 10 | |
University of Gottingen
10
| College/University | Other Consumer Services | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marcus Schindler via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MORGAN STANLEY | Investment Managers | President Corporate Officer/Principal | |
| 3I GROUP PLC | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Goldman Sachs Asset Management LP
 Goldman Sachs Asset Management LP Investment ManagersFinance Goldman Sachs Asset Management LP (GSAMLP) is a SEC-registered investment advisor headquartered in New York City. The firm is a wholly owned subsidiary of GSAM Holdings LLC, and their ultimate parent is Goldman Sachs Group, Inc. (NYSE: GS). Founded in 1988, GSAMLP provides investment solutions to a range of individual and institutional investors worldwide. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| DADA SPA | Internet Software/Services | Chief Executive Officer Director/Board Member | |
| CARLSBERG A/S | Beverages: Alcoholic | Director/Board Member Chairman | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Chief Executive Officer Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Director/Board Member Chairman | |
| Imperial College London | College/University | Corporate Officer/Principal Undergraduate Degree | |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
EDB Investments Pte Ltd.
 EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| The University of Southampton | College/University | Corporate Officer/Principal Undergraduate Degree | |
Lehman Brothers Bancorp, Inc.
 Lehman Brothers Bancorp, Inc. Regional BanksFinance Lehman Brothers Bancorp, Inc. provides banking and financial services. It offers savings, credit cards, and brokerage and mortgage services. The firm also provides home financing, asset based lending, and residential real estate finance. The company was founded in 1850 and is headquartered in Wilmington, DE. | Regional Banks | Corporate Officer/Principal | |
| University of Hong Kong | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Edinburgh | College/University | Doctorate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Undergraduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Undergraduate Degree | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Director of Finance/CFO President Director/Board Member | |
| NNIT A/S | Information Technology Services | Chairman Director/Board Member Corporate Officer/Principal | |
| University of Copenhagen | College/University | Chairman Graduate Degree Doctorate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| École des Hautes Études Commerciales de Paris | College/University | Director/Board Member Masters Business Admin | |
Novo Nordisk Health Care AG
 Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Novo Nordisk Haemophilia Foundation | Corporate Officer/Principal Corporate Officer/Principal | ||
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
Novo Nordisk Region Aameo & Latam A/S
 Novo Nordisk Region Aameo & Latam A/S Financial ConglomeratesFinance Novo Nordisk Region International Operations A/S holds ownership interests in companies that operates within investment and financing activities. The firm also invests capital in companies and real estate. The company was founded in January 1, 2002 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Consultant / Advisor | |
| University of Kent | College/University | Graduate Degree Doctorate Degree | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The private company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
Novo Nordisk Region Europe A/S
 Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman | |
| ESSEC Business School | College/University | Masters Business Admin Graduate Degree | |
BlackRock Financial Management, Inc.
 BlackRock Financial Management, Inc. Investment ManagersFinance BlackRock Financial Management, Inc. (BFM) is a registered investment advisor headquartered in New York City. The firm was founded in 1994 and is a direct subsidiary of BlackRock Holdco 2, Inc., ultimately held by BlackRock, Inc. (NYSE: BLK). BFM manages assets for institutional and high net-worth clients, separate accounts, pooled investment vehicles, private investment funds and US registered investment companies. | Investment Managers | Head-Fixed Income Invts | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| R3 Capital Management LLC | Corporate Officer/Principal |
Statistics
International
| Denmark | 17 |
| United Kingdom | 14 |
| United States | 10 |
| France | 4 |
| Italy | 2 |
Sectoral
| Consumer Services | 15 |
| Finance | 12 |
| Health Technology | 9 |
| Commercial Services | 5 |
| Consumer Non-Durables | 4 |
Operational
| Director/Board Member | 447 |
| Corporate Officer/Principal | 162 |
| Chief Executive Officer | 121 |
| Chairman | 96 |
| Independent Dir/Board Member | 85 |
Most connected contacts
| Insiders | |
|---|---|
| Helene von Roeder | 82 |
| Göran Albert Ando | 44 |
| Johnson Chen | 42 |
| Simon Holden | 40 |
| Henrik Poulsen | 37 |
| Chin Toh Wong | 36 |
| Martin Murphy | 33 |
| Martin MacKay | 28 |
| Sylvie Grégoire | 25 |
| Jesper Brandgaard | 25 |
| Claudio Corbetta | 24 |
| Helge Lund | 24 |
| Andreas Fibig | 21 |
| Kasim Kutay | 21 |
| Brian Daniels | 20 |
- Stock Market
- Insiders
- Marcus Schindler
- Company connections
